Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Prepaid Assets (2017 - 2025)

Arcus Biosciences (RCUS) has 7 years of Prepaid Assets data on record, last reported at $20.0 million in Q2 2024.

  • For Q2 2024, Prepaid Assets changed N/A year-over-year to $20.0 million; the TTM value through Jun 2024 reached $20.0 million, changed N/A, while the annual FY2022 figure was $19.0 million, 18.75% up from the prior year.
  • Prepaid Assets reached $20.0 million in Q2 2024 per RCUS's latest filing, up from $19.0 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $22.0 million in Q2 2021 and bottomed at $5.5 million in Q4 2020.
  • Average Prepaid Assets over 4 years is $14.8 million, with a median of $16.0 million recorded in 2021.
  • Peak YoY movement for Prepaid Assets: skyrocketed 192.45% in 2021, then fell 28.66% in 2022.
  • A 4-year view of Prepaid Assets shows it stood at $5.5 million in 2020, then surged by 192.45% to $16.0 million in 2021, then grew by 18.75% to $19.0 million in 2022, then increased by 5.26% to $20.0 million in 2024.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $20.0 million in Q2 2024, $19.0 million in Q4 2022, and $21.6 million in Q3 2022.